Mutual of America Capital Management LLC Has $281,000 Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Mutual of America Capital Management LLC cut its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 9.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,434 shares of the company’s stock after selling 1,629 shares during the period. Mutual of America Capital Management LLC’s holdings in Privia Health Group were worth $281,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Sequoia Financial Advisors LLC raised its stake in Privia Health Group by 2.3% in the third quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after purchasing an additional 583 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its position in shares of Privia Health Group by 8.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock valued at $134,000 after buying an additional 605 shares in the last quarter. Arizona State Retirement System lifted its holdings in shares of Privia Health Group by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock worth $462,000 after acquiring an additional 617 shares during the period. Signaturefd LLC boosted its position in shares of Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after acquiring an additional 626 shares in the last quarter. Finally, Parkside Financial Bank & Trust increased its stake in Privia Health Group by 9.7% in the second quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company’s stock valued at $151,000 after acquiring an additional 771 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This trade represents a 35.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 14.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on PRVA shares. Robert W. Baird raised their target price on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. Truist Financial lifted their target price on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Barclays boosted their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. KeyCorp began coverage on Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective on the stock. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $28.00 target price on shares of Privia Health Group in a report on Wednesday, August 14th. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Privia Health Group currently has a consensus rating of “Buy” and a consensus price target of $25.07.

Privia Health Group Price Performance

PRVA stock opened at $21.66 on Friday. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $24.30. The stock has a market capitalization of $2.60 billion, a PE ratio of 216.60, a price-to-earnings-growth ratio of 5.60 and a beta of 0.76. The company’s 50-day moving average is $19.14 and its 200-day moving average is $18.65.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.